drugset / Trial / NCT07205926
First in Human Dose Escalation Study Evaluating the Safety and Immunogenicity of IVT's Shigella-04 Vaccine in Healthy Young Adults
RandomizedParallel-groupDouble-blindPrevention
Summary
Phase 1 trial to evaluate the Safety and Immunogenicity of Inventprise's (IVT) Shigella-04 in Healthy Young Adults
Timeline
- Start
- 2025-10-09
- Primary completion
- 2026-01-26
- Completion
- 2026-08-21
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | IVT Shigella-04 | Vaccine | 0.5 ml | Intramuscular |
| Subject | IVT Shigella-04 | Vaccine | 1 ml | Intramuscular |